Clinical Trial Update: Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of adding saxagliptin and dapagliflozin to metformin in patients with type 2 diabetes mellitus, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Onglyza (Saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2015-10-20